
- Pharmaceutical Executive-02-01-2012
- Volume 0
- Issue 0
Torrent: Indian Success, Brazilian Ways
Torrent's affiliate in Brazil has become the India-based company's biggest.
Orlando Famá, the head of Indian firm Torrent in Brazil, is self-effacing when talking of the affiliate's success. "What happened with Torrent in Brazil is that we did not imagine that we would be so good in the beginning!" he says. "In the beginning we were doubling sales almost monthly. One of things we did to achieve this result was, my boss—a very smart man responsible for many countries as well as Brazil—he understood the pharmaceutical market. He understood the Brazilian culture, and he helped us to launch a company with a Brazilian profile even though we were an Indian company."
Orlando Famá, president, Torrent
From its start in 2002, under Famá's leadership the Brazilian affiliate became the company's biggest by 2009, having launched 19 products in the cardiovascular (CVS), central nervous system (CNS) and Oral Anti-Diabetic segments. Famá stresses that India is completely different from Brazil. He refers to an earlier time when an anonymous assistant of an executive suggested an approach a la India. "He wanted me to handle the marketing like in India, with the same way of promoting, the same approach, the same strategy, and the same culture. He wanted us to have dinner with doctors in Indian restaurants!" Famá politely declined. "I told him we are not launching in India. We are not selling India. What we have to sell is the quality of our company and the quality of the products that we have. Let us show them that we have high quality with a lower price."
Articles in this issue
over 13 years ago
Pharmaceutical Executive Digital Edition - February 2012over 13 years ago
How to Choose a Medical Animatorover 13 years ago
Money for Nothing, Patents for Free?over 13 years ago
Trying Trials at GC-2over 13 years ago
Prizing the Eye : Brent Saunders, CEO Bausch + Lombover 13 years ago
Brand Success: It's Not Serendipityover 13 years ago
Brazil Report: A Bold Player Bloomsover 13 years ago
Of Farms, Beaches … and Genericsover 13 years ago
FDA Social Media Guidelines: Irresponsible?over 13 years ago
Time to Appoint a 'Chief Patient Officer'?Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.